MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Can we hear pathology in premanifest Huntington’s disease? Acoustic and listener-based analysis of speech

J. Chan, C. Shirbin, J. Stout, A. Vogel (Melbourne, Australia)

Meeting: 2019 International Congress

Abstract Number: 3

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Dysarthria

Session Information

Date: Monday, September 23, 2019

Session Title: Huntington’s Disease

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: The present study evaluated the ability of acoustic and listener-based perceptual measures to differentiate speech deficits in the premanifest and early stages of HD (EarlyHD).

Background: Dysarthria is common in Huntington’s disease, however, our understanding of how speech is expressed in the premanifest phase (PreHD) remains unclear.

Method: We quantified speech characteristics in a group of 13 people with PreHD, 17 with EarlyHD, and 15 neurologically healthy controls using sustained vowel and connected speech samples.

Results: Listener-based assessment detected speech deficits that were in-line with disease progression. Although not reaching significance, perceptual analyses showed a higher occurrence of voice disorder, altered prosody and speech-timing in speakers with PreHD compared to healthy controls. Perceptual analyses also revealed a significant, mild to moderate level of impairment across measures of voice quality, prosody, articulation, intelligibility and naturalness in speakers with EarlyHD. Acoustic analyses did not reveal a significant difference between PreHD and control groups, nor a significant difference between EarlyHD and controls. Contrary to acoustic analyses results, dysphonia was reported in approximately 70% of people with EarlyHD using perceptual assessment.

Conclusion: Perceptual evaluations indicated that subtle changes in speech precede a clinical diagnosis of HD, and demonstrated a higher incidence of speech impairment in EarlyHD. Instrumental evaluation of speech, however, was not sufficient to distinguish speech patterns in premanifest and EarlyHD. The present study demonstrates a need for a more sensitive acoustic speech battery to better identify and intervene speech disorders in HD.

To cite this abstract in AMA style:

J. Chan, C. Shirbin, J. Stout, A. Vogel. Can we hear pathology in premanifest Huntington’s disease? Acoustic and listener-based analysis of speech [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/can-we-hear-pathology-in-premanifest-huntingtons-disease-acoustic-and-listener-based-analysis-of-speech/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/can-we-hear-pathology-in-premanifest-huntingtons-disease-acoustic-and-listener-based-analysis-of-speech/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley